| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $2.14B | $1.96B | $1.91B |
| YoY Revenue Growth % | +9.0% | +2.3% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $441.2M | $453.5M | $231.3M |
| Operating Margin % | 20.6% | 23.1% | 12.1% |
| Net Income (GAAP) | $169.8M | $258.7M | $106.9M |
| EBITDA (Normalized) | $518.1M | $524.0M | $300.3M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $584.5M | $508.2M | $551.2M |
| Capital Expenditures (CapEx) | $96.2M | $88.2M | $86.2M |
| Free Cash Flow (FCF) | $488.3M | $420.0M | $465.0M |
| FCF Margin % | 22.9% | 21.4% | 24.3% |
| Return on Invested Capital (ROIC %) | 4.1% | 5.2% | 8.5% |
| Cash & Short-Term Equivalents | $18.3M | $4.5M | — |
| Total Debt (Short + Long Term) | $5.12B | $4.31B | $831.3M |
| Total Stockholders' Equity | $3.40B | $2.54B | $1.71B |